Audit of the autoantibody test, EarlyCDT®-Lung, in 1600 patients: An evaluation of its performance in routine clinical practice

2013241 citationsJournal Articlehybrid Open Access

Authors

James R. Jett · National Jewish Health

Laura J. Peek · OncoImmune (United States)

Lynn Fredericks · OncoImmune (United States)

William R. Jewell · OncoImmune (United States)

William W. Pingleton · OncoImmune (United States)

J.F.R. Robertson · Astrimmune (United Kingdom)

Abstract

EarlyCDT-Lung has been extensively tested and validated in case-control settings and has now been shown in this audit to perform in routine clinical practice as predicted. EarlyCDT-Lung may be a complementary tool to CT for detection of early lung cancer.

Topics & Keywords

Lung Cancer Diagnosis and Treatment Lung Cancer Research Studies Lung Cancer Treatments and Mutations

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Lung Cancer

Volume 83, Issue 1, pp. 51-55

DOI: 10.1016/j.lungcan.2013.10.008

Field-Weighted Citation Impact: 7.10